Project Description

Commercial Manufacturing Facility
El Segundo, CA

The new 45,000 sf state-of-the-art, industrial cGMP manufacturing facility enables the development of novel cancer immunotherapy products to be used for clinical trials in the treatment of patients with blood cancer.  Equipped with numerous resources, the space houses manufacturing, quality assurance, IT, research and development office space, and warehousing.